Literature DB >> 28976859

Challenges in the Design and Interpretation of Noninferiority Trials.

Laura Mauri1, Ralph B D'Agostino1.   

Abstract

Mesh：

Year:  2017        PMID： 28976859     DOI： 10.1056/NEJMra1510063

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

1.  Value-Based Care for Musculoskeletal Pain: Are Physical Therapists Ready to Deliver?

Authors:  Trevor A Lentz; Adam P Goode; Charles A Thigpen; Steven Z George
Journal:  Phys Ther       Date:  2020-04-17

2.  Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.

Authors:  Irene S Yu; Allan A L Pereira; Michael Lee; Kritti Korphaisarn; John Marshall; Eva Segelov; Chris O'Callaghan; Howard J Lim; Scott Kopetz; Jonathan M Loree
Journal:  Oncologist       Date:  2019-10-22

3.  ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.

Authors:  Matthew Castelo; Adena S Scheer
Journal:  Ann Surg Oncol       Date:  2020-03-23       Impact factor: 5.344

4.  Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.

Authors:  Helena Earl; Louise Hiller; Anne-Laure Vallier; Shrushma Loi; Karen McAdam; Luke Hughes-Davies; Daniel Rea; Donna Howe; Kerry Raynes; Helen B Higgins; Maggie Wilcox; Chris Plummer; Betania Mahler-Araujo; Elena Provenzano; Anita Chhabra; Sophie Gasson; Claire Balmer; Jean E Abraham; Carlos Caldas; Peter Hall; Bethany Shinkins; Christopher McCabe; Claire Hulme; David Miles; Andrew M Wardley; David A Cameron; Janet A Dunn
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

5.  Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.

Authors:  Irene S Yu; Allan A L Pereira; Michael Lee; Kritti Korphaisarn; John Marshall; Eva Segelov; Chris O'Callaghan; Howard J Lim; Scott Kopetz; Jonathan M Loree
Journal:  Oncologist       Date:  2019-10-22

6.  Including Non-inferiority Trials in Contemporary Meta-analyses of Chronic Medical Conditions: a Meta-epidemiological Study.

Authors:  Zhen Wang; Tarek Nayfeh; Nigar Sofiyeva; Oscar J Ponte; Rami Rajjoub; Konstantinos Malandris; Mohamed Seisa; Haitao Chu; Mohammad Hassan Murad
Journal:  J Gen Intern Med       Date:  2020-04-21       Impact factor: 5.128

Review 7.  Design and conduct of confirmatory chronic pain clinical trials.

Authors:  Nathaniel Katz
Journal:  Pain Rep       Date:  2020-12-18

8.  Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.

Authors:  Sarah B Doernberg; Thuy Tien Tram Tran; Steven Y C Tong; Mical Paul; Dafna Yahav; Joshua S Davis; Leonard Leibovici; Helen W Boucher; G Ralph Corey; Sara E Cosgrove; Henry F Chambers; Vance G Fowler; Scott R Evans; Thomas L Holland
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

9.  Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials.

Authors:  Behnood Bikdeli; César Caraballo; John Welsh; Joseph S Ross; Sanjay Kaul; Gregg W Stone; Harlan M Krumholz
Journal:  Clin Trials       Date:  2020-08-24       Impact factor: 2.486

10.  The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.

Authors:  Ismail Jatoi; Mitchell H Gail
Journal:  JAMA Oncol       Date:  2020-03-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.